Skip to main content
Erschienen in: Current Rheumatology Reports 2/2011

01.04.2011

The Role of Uric Acid as an Endogenous Danger Signal in Immunity and Inflammation

verfasst von: Faranak Ghaemi-Oskouie, Yan Shi

Erschienen in: Current Rheumatology Reports | Ausgabe 2/2011

Einloggen, um Zugang zu erhalten

Abstract

Gout is an ancient disease that still plagues us. Its pathogenic culprit, uric acid crystal deposition in tissues, is a strong inflammatory stimulant. In recent years, the mechanisms through which uric acid crystals promote inflammation have been a subject of increasing interest among rheumatologists and immunologists. Uric acid has been identified as an endogenous adjuvant that drives immune responses in the absence of microbial stimulation. Because uric acid is a ubiquitous metabolite that is produced in high quantities upon cellular injury, the ramifications of its effects may be considerable in health and in disease. Uric acid crystals also have been shown to trigger interleukin-1β–mediated inflammation via activation of the NOD-like receptor protein (NLRP)3 inflammasome, a multimolecular complex whose activation appears to be central to many pathological inflammatory conditions. In this article, we review the possible mechanisms of uric acid–mediated inflammation and offer some historical perspectives on what has been learned about the complex effects of a relatively simple substance.
Literatur
1.
Zurück zum Zitat Dunn JP, Brooks GW, Mausner J, Rodnan GP, Cobb S. Social class gradient of serum uric acid levels in males. JAMA. 1963; 185:431-6. Dunn JP, Brooks GW, Mausner J, Rodnan GP, Cobb S. Social class gradient of serum uric acid levels in males. JAMA. 1963; 185:431-6.
2.
Zurück zum Zitat •• Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol. 2010; 6:30-8. This is a comprehensive and contemporary review of gout. PubMedCrossRef •• Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol. 2010; 6:30-8. This is a comprehensive and contemporary review of gout. PubMedCrossRef
3.
Zurück zum Zitat Smyth CJ, Holers VM. Gout, Hyperuricemia, and Other Crystal-Associated Arthropathies. New York: Marcel Dekker, 1998. Smyth CJ, Holers VM. Gout, Hyperuricemia, and Other Crystal-Associated Arthropathies. New York: Marcel Dekker, 1998.
4.
Zurück zum Zitat Enomoto A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature. 2002; 417:447-52.PubMed Enomoto A, et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature. 2002; 417:447-52.PubMed
5.
Zurück zum Zitat Hooper DC, et al. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 1998; 95:675-80.PubMedCrossRef Hooper DC, et al. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 1998; 95:675-80.PubMedCrossRef
6.
Zurück zum Zitat Seet RCS, et al. Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study. Atherosclerosis. 2010; 209:215-9.PubMedCrossRef Seet RCS, et al. Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study. Atherosclerosis. 2010; 209:215-9.PubMedCrossRef
7.
Zurück zum Zitat Watanabe S, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension. 2002; 40:355-60.PubMedCrossRef Watanabe S, et al. Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity. Hypertension. 2002; 40:355-60.PubMedCrossRef
9.
Zurück zum Zitat Kanevets U, Sharma K, Dresser K, Shi Y. A role of IgM antibodies in monosodium urate crystal formation and associated adjuvanticity. J Immunol. 2009; 182:1912-8.PubMedCrossRef Kanevets U, Sharma K, Dresser K, Shi Y. A role of IgM antibodies in monosodium urate crystal formation and associated adjuvanticity. J Immunol. 2009; 182:1912-8.PubMedCrossRef
10.
Zurück zum Zitat Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003; 425:516-21.PubMedCrossRef Shi Y, Evans JE, Rock KL. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature. 2003; 425:516-21.PubMedCrossRef
12.
Zurück zum Zitat Vitart V, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008; 40:437-42.PubMedCrossRef Vitart V, et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet. 2008; 40:437-42.PubMedCrossRef
13.
Zurück zum Zitat Schlesinger N, Norquist JM, Watson DJ. Serum urate during acute gout. J Rheumatol. 2009; 36:1287-9.PubMedCrossRef Schlesinger N, Norquist JM, Watson DJ. Serum urate during acute gout. J Rheumatol. 2009; 36:1287-9.PubMedCrossRef
14.
Zurück zum Zitat Fiddis RW, Vlachos N, Calvert PD. Studies of urate crystallisation in relation to gout. Ann Rheum Dis. 1983; 42 Suppl 1:12-5.PubMedCrossRef Fiddis RW, Vlachos N, Calvert PD. Studies of urate crystallisation in relation to gout. Ann Rheum Dis. 1983; 42 Suppl 1:12-5.PubMedCrossRef
15.
Zurück zum Zitat Iwata H, Nishio S, Yokoyama M, Matsumoto A, Takeuchi M. Solubility of uric acid and supersaturation of monosodium urate: why is uric acid so highly soluble in urine? J Urol. 1989; 142:1095-8.PubMed Iwata H, Nishio S, Yokoyama M, Matsumoto A, Takeuchi M. Solubility of uric acid and supersaturation of monosodium urate: why is uric acid so highly soluble in urine? J Urol. 1989; 142:1095-8.PubMed
16.
Zurück zum Zitat Kippen I, Klinenberg JR, Weinberger A, Wilcox WR. Factors affecting urate solubility in vitro. Ann Rheum Dis. 1974; 33:313-7.PubMedCrossRef Kippen I, Klinenberg JR, Weinberger A, Wilcox WR. Factors affecting urate solubility in vitro. Ann Rheum Dis. 1974; 33:313-7.PubMedCrossRef
17.
Zurück zum Zitat Tak HK, Cooper SM, Wilcox WR. Studies on the nucleation of monosodium urate at 37 degrees c. Arthritis Rheum. 1980; 23:574-80.PubMedCrossRef Tak HK, Cooper SM, Wilcox WR. Studies on the nucleation of monosodium urate at 37 degrees c. Arthritis Rheum. 1980; 23:574-80.PubMedCrossRef
18.
Zurück zum Zitat Kam M, Perl-Treves D, Caspi D, Addadi L. Antibodies against crystals. FASEB J. 1992; 6:2608-13.PubMed Kam M, Perl-Treves D, Caspi D, Addadi L. Antibodies against crystals. FASEB J. 1992; 6:2608-13.PubMed
19.
Zurück zum Zitat Kam M, Perl-Treves D, Sfez R, Addadi L. Specificity in the recognition of crystals by antibodies. J Mol Recognit. 1994; 7:257-64.PubMedCrossRef Kam M, Perl-Treves D, Sfez R, Addadi L. Specificity in the recognition of crystals by antibodies. J Mol Recognit. 1994; 7:257-64.PubMedCrossRef
20.
Zurück zum Zitat Landis RC, Haskard DO. Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep. 2001; 3:36-41.PubMedCrossRef Landis RC, Haskard DO. Pathogenesis of crystal-induced inflammation. Curr Rheumatol Rep. 2001; 3:36-41.PubMedCrossRef
21.
Zurück zum Zitat Nagase M, Baker DG, Schumacher HR, Jr. Immunoglobulin G coating on crystals and ceramics enhances polymorphonuclear cell superoxide production: correlation with immunoglobulin G adsorbed. J Rheumatol. 1989; 16:971-6.PubMed Nagase M, Baker DG, Schumacher HR, Jr. Immunoglobulin G coating on crystals and ceramics enhances polymorphonuclear cell superoxide production: correlation with immunoglobulin G adsorbed. J Rheumatol. 1989; 16:971-6.PubMed
22.
Zurück zum Zitat Ortiz-Bravo E, Sieck MS, Schumacher HR, Jr. Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum. 1993; 36:1274-85.PubMedCrossRef Ortiz-Bravo E, Sieck MS, Schumacher HR, Jr. Changes in the proteins coating monosodium urate crystals during active and subsiding inflammation. Immunogold studies of synovial fluid from patients with gout and of fluid obtained using the rat subcutaneous air pouch model. Arthritis Rheum. 1993; 36:1274-85.PubMedCrossRef
23.
Zurück zum Zitat Kozin F, McCarty DJ. Molecular orientation of immunoglobulin G adsorbed to microcrystalline monosodium urate monohydrate. J Lab Clin Med. 1980; 95:49-58.PubMed Kozin F, McCarty DJ. Molecular orientation of immunoglobulin G adsorbed to microcrystalline monosodium urate monohydrate. J Lab Clin Med. 1980; 95:49-58.PubMed
24.
Zurück zum Zitat Barabe F, Gilbert C, Liao N, Bourgoin SG, Naccache PH. Crystal-induced neutrophil activation VI. Involvment of FcgammaRIIIB (CD16) and CD11b in response to inflammatory microcrystals. FASEB J. 1998; 12:209-20.PubMed Barabe F, Gilbert C, Liao N, Bourgoin SG, Naccache PH. Crystal-induced neutrophil activation VI. Involvment of FcgammaRIIIB (CD16) and CD11b in response to inflammatory microcrystals. FASEB J. 1998; 12:209-20.PubMed
25.
Zurück zum Zitat Desaulniers P, Fernandes M, Gilbert C, Bourgoin SG, Naccache PH. Crystal-induced neutrophil activation. VII. Involvement of Syk in the responses to monosodium urate crystals. J Leukoc Biol. 2001; 70:659-68.PubMed Desaulniers P, Fernandes M, Gilbert C, Bourgoin SG, Naccache PH. Crystal-induced neutrophil activation. VII. Involvement of Syk in the responses to monosodium urate crystals. J Leukoc Biol. 2001; 70:659-68.PubMed
26.
Zurück zum Zitat Terkeltaub R, Tenner AJ, Kozin F, Ginsberg MH. Plasma protein binding by monosodium urate crystals. Analysis by two-dimensional gel electrophoresis. Arthritis Rheum. 1983; 26:775-83.PubMedCrossRef Terkeltaub R, Tenner AJ, Kozin F, Ginsberg MH. Plasma protein binding by monosodium urate crystals. Analysis by two-dimensional gel electrophoresis. Arthritis Rheum. 1983; 26:775-83.PubMedCrossRef
27.
Zurück zum Zitat Naff GB, Byers PH. Complement as a mediator of inflammation in acute gouty arthritis. I. Studies on the reaction between human serum complement and sodium urate crystals. J Lab Clin Med. 1973; 81:747-60.PubMed Naff GB, Byers PH. Complement as a mediator of inflammation in acute gouty arthritis. I. Studies on the reaction between human serum complement and sodium urate crystals. J Lab Clin Med. 1973; 81:747-60.PubMed
28.
Zurück zum Zitat Fields TR, Abramson SB, Weissmann G, Kaplan AP, Ghebrehiwet B. Activation of the alternative pathway of complement by monosodium urate crystals. Clin Immunol Immunopathol. 1983; 26:249-57.PubMedCrossRef Fields TR, Abramson SB, Weissmann G, Kaplan AP, Ghebrehiwet B. Activation of the alternative pathway of complement by monosodium urate crystals. Clin Immunol Immunopathol. 1983; 26:249-57.PubMedCrossRef
29.
Zurück zum Zitat Tramontini N, Huber C, Liu-Bryan R, Terkeltaub RA, Kilgore KS. Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis. Arthritis Rheum. 2004; 50:2633-9.PubMedCrossRef Tramontini N, Huber C, Liu-Bryan R, Terkeltaub RA, Kilgore KS. Central role of complement membrane attack complex in monosodium urate crystal-induced neutrophilic rabbit knee synovitis. Arthritis Rheum. 2004; 50:2633-9.PubMedCrossRef
30.
Zurück zum Zitat Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol. 2005; 174:5016-23.PubMed Liu-Bryan R, Pritzker K, Firestein GS, Terkeltaub R. TLR2 signaling in chondrocytes drives calcium pyrophosphate dihydrate and monosodium urate crystal-induced nitric oxide generation. J Immunol. 2005; 174:5016-23.PubMed
31.
Zurück zum Zitat Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 2005; 52:2936-46.PubMedCrossRef Liu-Bryan R, Scott P, Sydlaske A, Rose DM, Terkeltaub R. Innate immunity conferred by Toll-like receptors 2 and 4 and myeloid differentiation factor 88 expression is pivotal to monosodium urate monohydrate crystal-induced inflammation. Arthritis Rheum. 2005; 52:2936-46.PubMedCrossRef
32.
Zurück zum Zitat Scott P, Ma H, Viriyakosol S, Terkeltaub R, Liu-Bryan R. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol. 2006; 177:6370-8.PubMed Scott P, Ma H, Viriyakosol S, Terkeltaub R, Liu-Bryan R. Engagement of CD14 mediates the inflammatory potential of monosodium urate crystals. J Immunol. 2006; 177:6370-8.PubMed
33.
Zurück zum Zitat Chen CJ, et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest. 2006; 116:2262-71.PubMedCrossRef Chen CJ, et al. MyD88-dependent IL-1 receptor signaling is essential for gouty inflammation stimulated by monosodium urate crystals. J Clin Invest. 2006; 116:2262-71.PubMedCrossRef
34.
Zurück zum Zitat • Ng G, et al. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity. 2008; 29:807-18. This report suggests lipid sorting may be a mechanism for MSU-mediated activation. PubMedCrossRef • Ng G, et al. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity. 2008; 29:807-18. This report suggests lipid sorting may be a mechanism for MSU-mediated activation. PubMedCrossRef
35.
Zurück zum Zitat Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440:237-41.PubMedCrossRef Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440:237-41.PubMedCrossRef
36.
Zurück zum Zitat • Hoffman HM, et al. Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice. Arthritis Rheum. 2010; 62:2170-9. This article presents structural insight into how NLRP3 may handle MSU-initiated activation. PubMed • Hoffman HM, et al. Role of the leucine-rich repeat domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation in mice. Arthritis Rheum. 2010; 62:2170-9. This article presents structural insight into how NLRP3 may handle MSU-initiated activation. PubMed
37.
Zurück zum Zitat Eisenbarth SC, Colegio OR, O’Connor W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 2008; 453:1122-6.PubMedCrossRef Eisenbarth SC, Colegio OR, O’Connor W, Sutterwala FS, Flavell RA. Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature. 2008; 453:1122-6.PubMedCrossRef
38.
Zurück zum Zitat Kool M, et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med. 2008; 205:869-82.PubMedCrossRef Kool M, et al. Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells. J Exp Med. 2008; 205:869-82.PubMedCrossRef
39.
Zurück zum Zitat Kool M, et al. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol. 2008; 181:3755-9.PubMed Kool M, et al. Cutting edge: alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol. 2008; 181:3755-9.PubMed
40.
Zurück zum Zitat •• Hornung V, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008; 9:847-56. This article discusses a potential pathway for MSU-mediated IL-1β production. PubMedCrossRef •• Hornung V, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008; 9:847-56. This article discusses a potential pathway for MSU-mediated IL-1β production. PubMedCrossRef
41.
42.
Zurück zum Zitat Mandel NS. The structural basis of crystal-induced membranolysis. Arthritis Rheum. 1976; 19 Suppl 3:439-45.PubMedCrossRef Mandel NS. The structural basis of crystal-induced membranolysis. Arthritis Rheum. 1976; 19 Suppl 3:439-45.PubMedCrossRef
43.
Zurück zum Zitat Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med. 2007; 13:851-6.PubMedCrossRef Chen CJ, Kono H, Golenbock D, Reed G, Akira S, Rock KL. Identification of a key pathway required for the sterile inflammatory response triggered by dying cells. Nat Med. 2007; 13:851-6.PubMedCrossRef
44.
Zurück zum Zitat Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008; 359:1811-21.PubMedCrossRef Feig DI, Kang DH, Johnson RJ. Uric acid and cardiovascular risk. N Engl J Med. 2008; 359:1811-21.PubMedCrossRef
Metadaten
Titel
The Role of Uric Acid as an Endogenous Danger Signal in Immunity and Inflammation
verfasst von
Faranak Ghaemi-Oskouie
Yan Shi
Publikationsdatum
01.04.2011
Verlag
Current Science Inc.
Erschienen in
Current Rheumatology Reports / Ausgabe 2/2011
Print ISSN: 1523-3774
Elektronische ISSN: 1534-6307
DOI
https://doi.org/10.1007/s11926-011-0162-1

Weitere Artikel der Ausgabe 2/2011

Current Rheumatology Reports 2/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.